Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genentech, Amgen Face Big Impact From Part B International Pricing Index

Oct 31 2018

• By Cathy Kelly

Related Content

Can Medicare International Price Index Model Avoid Part B Demo Pitfalls?

Oct 28 2018

Related Companies

Genentech, Inc.

Amgen, Inc.

Bristol Myers Squibb Company

Regeneron Pharmaceuticals, Inc.

Additional Topics

Pricing Debate Market Access Regulation BioPharmaceutical Cancer Immune Disorders

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window